Pfizer, Inc.
| Name | Area | Department | Start Year | Stop Year | Advisor |
|---|---|---|---|---|---|
| Robert A. Durham | Alzheimer's, drug discovery | Lary C. Walker (post-doc) | |||
| Robert C. Alexander | neuroscience drug development | ||||
| Talis A. Reks | Neuro / Imaging | ||||
| Heyi Li | |||||
| Riveri Malian | Neuropharmacology | ||||
| J. Brent Kuzmiski | synaptic transmission | ||||
| Farzana Karim | |||||
| Holly D. Soares | |||||
| Kristina H. Holmberg | Neuroanatony, Pharmacoanatomy | ||||
| Sean D. Donevan | |||||
| Karin Wallace | |||||
| Rouba Kozak | Neuropsychopharmacology | ||||
| Judy A. Siuciak | BDNF, phosphodiesterases | ||||
| Feng Bian | Alzheimer's disease, drug discovery | Lary C. Walker (post-doc) | |||
| Shahnaz P. Yusaf | Ion Channels | ||||
| Jason A. Miranda | Neuroethology, Auditory system,Memory | 2009 | 2011 | John R. Huxter (post-doc) | |
| Eoin C. OConnor | psychology, glutamate, addiction, learning, memory, appetitive | 2007 | 2011 | Andy N. Mead (grad student) | |
| Katrina L. Paumier | Parkinson's and neuroprotective therapies | 2010 | 2013 | Warren D. Hirst (post-doc) | |
| Feng Pan | Neuroscience |